| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.2 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.23 | 0.2 |